Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Operating Income Growth
54.89%
Quarterly · Period ending:
LCTX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported54.89%period ending
Latest reported54.89%period ending
LCTX Quarterly Operating Income YoY % (-100.00% → 54.89%)
Year-over-year change
High-resolution chart · PNG
LCTX operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 18.3799% | |
| 30.8361% | |
| 28.7301% | |
| 44.1005% | |
| -25.3508% | |
| -73.1746% | |
| -91.6667% | |
| -57.1429% | |
| 33.3333% | |
| -9.0909% | |
| 41.6667% | |
| -140% | |
| -14.2857% | |
| -83.3333% | |
| 42.8571% | |
| -600% | |
| -800% | |
| -200% | |
| -162.5% | |
| 120% | |
| 116.6667% | |
| 50% | |
| -33.3333% | |
| -150% | |
| -100% | |
| -33.3333% | |
| -50% | |
| 0% | |
| 0% | |
| -50% | |
| 0% | |
| -100% |